CATALOGO DEI PRODOTTI DELLA RICERCA

SACERDOTI, David
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.809
EU - Europa 7.705
AS - Asia 7.569
SA - Sud America 1.051
Continente sconosciuto - Info sul continente non disponibili 472
AF - Africa 156
OC - Oceania 25
AN - Antartide 1
Totale 27.788
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.329
SG - Singapore 3.680
RU - Federazione Russa 3.489
CN - Cina 1.668
GB - Regno Unito 1.010
IT - Italia 813
BR - Brasile 800
VN - Vietnam 684
HK - Hong Kong 627
FR - Francia 607
IE - Irlanda 539
DE - Germania 291
KR - Corea 290
UA - Ucraina 281
SE - Svezia 248
CA - Canada 214
BD - Bangladesh 152
FI - Finlandia 147
ID - Indonesia 99
IN - India 93
AR - Argentina 88
NL - Olanda 58
EC - Ecuador 55
MX - Messico 47
TR - Turchia 42
AT - Austria 37
ES - Italia 35
CO - Colombia 33
JP - Giappone 33
ZA - Sudafrica 33
PL - Polonia 32
SV - El Salvador 28
CR - Costa Rica 27
GT - Guatemala 26
NI - Nicaragua 26
IQ - Iraq 25
AU - Australia 24
CW - ???statistics.table.value.countryCode.CW??? 23
HN - Honduras 23
PR - Porto Rico 23
CL - Cile 22
TG - Togo 21
PH - Filippine 20
BE - Belgio 18
BJ - Benin 17
PK - Pakistan 17
VE - Venezuela 17
NG - Nigeria 16
TT - Trinidad e Tobago 16
GP - Guadalupe 15
SA - Arabia Saudita 15
EG - Egitto 13
PE - Perù 13
AE - Emirati Arabi Uniti 12
LT - Lituania 12
UZ - Uzbekistan 12
JM - Giamaica 11
MY - Malesia 11
NP - Nepal 11
PY - Paraguay 11
RO - Romania 11
KE - Kenya 10
DZ - Algeria 9
JO - Giordania 9
MA - Marocco 9
AZ - Azerbaigian 8
IL - Israele 8
KZ - Kazakistan 8
AL - Albania 7
CZ - Repubblica Ceca 7
BB - Barbados 6
CH - Svizzera 6
HU - Ungheria 6
OM - Oman 6
PT - Portogallo 6
SC - Seychelles 6
TN - Tunisia 6
UY - Uruguay 6
BO - Bolivia 5
DO - Repubblica Dominicana 5
EE - Estonia 5
NO - Norvegia 5
BS - Bahamas 4
DK - Danimarca 4
KW - Kuwait 4
MD - Moldavia 4
QA - Qatar 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
BZ - Belize 3
IR - Iran 3
KG - Kirghizistan 3
LB - Libano 3
LV - Lettonia 3
PA - Panama 3
PS - Palestinian Territory 3
SI - Slovenia 3
SY - Repubblica araba siriana 3
XK - ???statistics.table.value.countryCode.XK??? 3
Totale 27.295
Salva come PNG Salva come JPEG
Città #
Ashburn 2.085
Singapore 1.855
San Jose 1.317
Moscow 954
Southend 842
Jacksonville 786
Dallas 630
Hong Kong 614
Chandler 548
Dublin 535
Council Bluffs 512
The Dalles 446
Verona 375
Beijing 307
Lawrence 261
Princeton 261
Wilmington 221
Ho Chi Minh City 217
Los Angeles 176
Santa Clara 148
Hanoi 138
Jinan 121
New York 117
Redondo Beach 111
Buffalo 105
Munich 102
Helsinki 101
São Paulo 93
Shenyang 81
Ann Arbor 80
Dong Ket 79
Jakarta 62
Milan 62
Tianjin 60
Sindelfingen 59
Nanjing 52
Montreal 51
Ningbo 51
Changsha 50
Orem 46
Houston 44
San Francisco 44
Seattle 43
Toronto 43
London 42
Columbus 41
Haikou 41
Hebei 41
Hangzhou 39
Chicago 38
Brooklyn 36
Guangzhou 36
Chennai 35
Rome 34
Zhengzhou 34
Taizhou 32
Fairfield 30
Nanchang 30
Nuremberg 30
Phoenix 30
Tokyo 30
Atlanta 29
Denver 29
Warsaw 29
Da Nang 28
North Bergen 28
Amsterdam 27
Boston 27
Frankfurt am Main 26
Norwalk 26
Managua 25
San Salvador 25
Taiyuan 25
Washington 25
Redwood City 23
Rio de Janeiro 23
Willemstad 23
Stockholm 22
Turku 22
Guayaquil 21
Haiphong 21
Lanzhou 21
Lomé 21
Falkenstein 20
Johannesburg 19
San José 19
Brussels 18
Mexico City 18
Cotonou 17
Guatemala City 17
San Diego 17
Lappeenranta 16
Naples 16
Vienna 16
Brasília 15
Charlotte 15
Manchester 15
Redmond 15
Jiaxing 14
Miami 14
Totale 16.311
Salva come PNG Salva come JPEG
Nome #
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (Internal and Emergency Medicine, (2018), 13, 5, (651-660), 10.1007/s11739-018-1835-9) 282
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 220
ALTERAZIONI DEI PARAMETRI ECO-COLOR-DOPPLER SPLANCNICI DI IPERTENSIONE PORTALE NELLA CIRROSI BILIARE PRIMITIVA E NELLA COLANGITE SCLEROSANTE: CONFRONTO CON LA CIRROSI POST-EPATICA E ALCOLICA 212
11,12-Epoxyeicosatrienoic acid stimulates heme-oxygenase-1 in endothelial cells 203
11,12-EET increases porto-sinusoidal resistance and may play a role in endothelial dysfunction of portal hypertension 200
A Phase 2a active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with nonalcoholic fatty liver disease 171
Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy 171
Interleukin-6: A New Marker of Advanced-Sarcopenic HCC Cirrhotic Patients 168
Alterazioni circolatorie splancniche e periferiche nella cirosi: studio mediante eco-color-doppler. Risultati a lungo termine del Centro Trapianti di Padova. 162
Accuracy and predictive value of echo-Doppler measurements in acute liver rejection -- initial experience 160
Hepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment 155
Alterations in thyroid Doppler arterial resistance indices, volume and hormones in cirrhosis: Relationships with splanchnic haemodynamics 152
Arteroportal fistulas between the accessory right hepatic, gastroduodenal and superior mesenteric arteries and portal vein: a difficult technical problem to overcome in liver transplantation 150
Arachidonic acid metabolites and endothelial dysfunction of portal hypertension 150
A CO-releaseng molecule, CORM-3, attenuates ischemia/reperfusion incurie in a new model in pig liver 148
Effects of direct-acting antiviral agents on lipid and glucose profile in HCV patients with type 2 diabetes: A real-life Italian experience 146
A Pig Model of Hemivascular Liver Occlusion for The Study of Ischemia-Reperfusion Injury: Use of an Infrared System for Detecting Ischemic Areas 145
Spur cells in liver cirrhosis are predictive of acute-on-chronic liver failure and liver-related mortality regardless of severe anaemia 143
Ankle-Brachial Index and cardiovascular events in atrial fibrillation: The ARAPACIS study 143
Subclinical and clinical atherosclerosis in Non-alcoholic Fatty Liver Disease is associated with the presence of hypertension 142
Arterioportal fistulas in patients with liver cirrhosis: Usefulness of color-Doppler US for screening 141
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 140
Alteration in endothelial function in cirrhosis 139
Metabolic-associated fatty liver disease and liver fibrosis scores as COVID-19 outcome predictors: a machine-learning application 137
Atrogin-1 deficiency promotes cardiomyopathy and premature death via impaired autophagy 137
Comparison of sublingual captopril and nifedipine in immediate treatment of hypertensive emergencies. A randomized, single-blind clinical trial 137
Assessment of intrarenal sodium handling by lithium clearance in cirrhotic patients with ascites 136
A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care ap¬proach to the diuretic treatment of ascites in non-azotemic cirrhotics 135
Bacterial infections as a risk factor for non-neoplastic portal vein thrombosis development in cirrhotic patients 133
Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant 133
I betabloccanti nel trattamento dell'ipertensione portale in corso di cirrosi epatica. Rapporti tra effetto sulla pressione portale e prevenzione della recidiva emorragica. 133
Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study 131
Hypoalbuminemia and Risk of Portal Vein Thrombosis in Cirrhosis 128
Effetti della ciclosporina sulla funzione renale e sul metabolismo renale citocromo P450-dipendente dell'acido arachidonico. 127
Urinary excretion of P450-Hetes: increase of 20-Hete in patients with cirrhosis 127
Frequency of Left Ventricular Hypertrophy in Non-Valvular Atrial Fibrillation 126
Prevalence of portal vein thrombosis in non-alcoholic fatty liver disease: a meta-analysis of observational studies 126
T Regulatory Lymphocytes Function Increased, by Induction Of Ho-1, Improves Type-1 Cardio-Renal Syndrome 124
Splenic Doppler impedance indeces: influence of different portal hemodynamic conditions. 123
Duplex Doppler ultrasonography allows a multiorgan noninvasive approach to splanchnic pharmacodynamics in patients with cirrhosis 123
The multi-drug resistant organisms infections decrease during the antimicrobial stewardship era in cirrhotic patients: An Italian cohort study 122
Alterazioni epatiche in corso di scompenso cardiaco 121
Hepatofugal portal flow is highly predictive of acute-on-chronic liver failure: A new hemodynamic patho-physiological hypothesis 119
Diagnostic accuracy of AGILE 3+ score for advanced fibrosis in patients with NAFLD: A systematic review and meta-analysis 119
Differential effects of cyclosporine A on hepatic and renal cytocrom P450 dependent metabolism of arachidonic acid. 119
Cholestatic HCV Cryoglobulinemia: A New Clinical and Pathological Entity before and after Direct-Acting Antiviral Therapies-A Case-Control Study 117
Effect of a dietary integration with BCAA or casein on nutritional state and lower limb amino acid exchange in cirrhosis 117
Q-T interval prolongation in liver cirrhosis - Reversibility after orthotopic liver transplantation 117
Heme-oxygenase-1 Induction Improves Type-1 Cardiorenal Syndrome Only In Mice With Impaired AngII-induced Lymphocyte Activation (SCID Mice) 116
Glomerular Hyperfiltration: A Marker of Fibrosis Severity in Metabolic Associated Steatotic Liver Disease in an Adult Population 115
Effetti del nadololo sull'emodinamica e sulla funzione renale, sul sistema renina-angiotensina-aldosterone e sulla produzione renale di PGE2 nei pazienti con cirrosi epatica ed ipertensione portale. 115
Effects of cyclosporine on renal function and cytochrome P450 -dependent metabolites of arachidonic acid metabolism 115
Relationship between renal prostaglandins and renal response to maximal water load in non ascitic liver cirrhosis. 114
Renal cytochrome P450-dependent metabolism of arachidonic acid in experimental liver cirrhosis 112
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 112
Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis 111
Hepatic vein catheterization in the prognostic evaluation in cirrhotics with esophageal varices 111
Comparison of computer psychometric tests (CPTs) and number connection test (NCT) in the detection of subclinical hepatic encephalophaty (SHE). 110
Variability of atrial natriuretic peptide plasma levels in ascitic chirrotics; pathophysiological and clinical implications 109
SPLENO-SYSTEMIC SHUNTS AND COVERT HEPATIC ENCEPHALOPATY 109
Early Diagnosis of Type-2 Cardio-renal Syndrome by Doppler Sonographic Evaluation of Renal Vasoconstriction 108
Eicosanoid excretion in hepatic cirrhosis - Predominance of 20-HETE 108
Evaluation angiografique semiquantitative de la perfusion portale chez les cirrhotiques: relations avec le debit plasmatique hepatiqhe.[lettre] 108
Interobserver and interequipment variability of hepatic, splenic, and renal arterial Doppler resistance indices in normal subjects and patients with cirhosis. J Hepatol 1997; 27: 986-992 (IF=4.974) 107
Magnesium deficiency (MD) in liver cirrhosis evaluated by intravenous load 107
Confronto tra Captopril e Nifedipina per via sublinguale nel trattamento delle emergenze ipertensive. 106
Aumento degli indici di resistenza arteriosa epatica nella cirrosi con e senza trombosi portale: rapporti con l'ipertensione portale. 106
Effect of nadolol on liver haemodynamics and function in patients with cirrhosis 105
Resistance to spironolactone in nonazotemic ascitic cirrhotic: role of enhanced proximal sodium reabsorption 105
Renal function in congestive heart failure. 104
Mesenteric arteries responsiveness to acute variations of wall shear stress is impaired in rats with liver cirrhosis 104
HEPATIC VEINS DOPPLER PROFILE MODIFICATIONS DURING ACUTE PORTAL PRESSURE INCREASE INDUCED BY PARAUMBILICAL VEIN COMPRESSION 104
Role of prostaglandins in the response to diuretic treatment of ascites in cirrhotic patients. 104
Incidence and Recurrence of Portal Vein Thrombosis in Cirrhotic Patients 104
Interobserver and inter-equipment variability of echo-Doppler evaluation of the superior mesenteric artery 104
Sistema vascolare epatico 103
Comparison of computer-based psychometric tests and number connection test in the detection of subclinical hepatic encephalopathy 103
Effetto protettivo del corm-3 nei confronti del danno da ischemia-riperfusione in un modello sperimentale porcino 103
Differential effects of cyclosporine A on hepatic and renal cytocrome P450 dependent metabolism of arachidonic acid. 101
La trombocitopenia dopo trapianto di fegato 101
Platelets in Non-alcoholic Fatty Liver Disease 101
Urinary excretion of P450-Hetes: increase of 20-Hete in patients with cirrhosis 100
Author's Reply: “Bacterial infections predispose to the development of portal vein thrombosis in patients with decompensated cirrhosis” 99
Efficacia di un trattamento diuretico organizzato per "steps" nella terapia dell'ascite in corso di cirrosi epatica. 99
Vascular disorders of the liver: recommendations from the Italian Association for the Study of the Liver (AISF) ad hoc committee 99
Chronic CO levels has a beneficial effect on vascular relaxation in diabetes 99
Role of prostaglandins in the response to diuretic treatment of ascites in cirrhotic patients. 98
Drugs in the prevention of rebleeding in cirrhosis 98
Imaging e valutazione emodinamica nella diagnostica epatologica 98
Left ventricular diastolic function in liver cirrhosis 98
Myocardial overexpression of ANKRD1 causes sinus venosus defects and progressive diastolic dysfunction 98
Effect of chronic treatment with nadolol plus isosorbide mononitrate on liver blood flow and liver metabolic activity in cirrhosis 98
Comparison of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Portal Vein Thrombosis in Cirrhosis 98
A MULTICENTER CONTROLLED-STUDY COMPARING BETA-BLOCKERS AND BETA-BLOCKERS PLUS NITRODERIVATIVES IN THE PRIMARY PROPHYLAXIS OF 1ST VARICEAL BLEEDING IN CIRRHOSIS - INTERIM ANALYSIS 97
La vasocostrizione renale in corso di cirrosi epatica: studio mediante eco-color doppler 97
Atrial natriuretic peptide (hANP) plasma levels in ascitic cirrhotics; a better selection of patients is needed ? 97
Effectiveness of a stepped care approach to diuretic treatment of ascites in cirrhotic patients 97
Effetti renali dei precursori della sintesi epatica di prostaglandine 97
Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort study 97
Absence of Viral Replication Is Associated With Improved Outcome in Anti-HCV-Positive Patients With Hepatocellular Carcinoma 96
Totale 12.415
Salva come PNG Salva come JPEG
Categoria #
all - tutte 116.329
article - articoli 91.786
book - libri 1.118
conference - conferenze 17.894
curatela - curatele 0
other - altro 581
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.950
Totale 232.658
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.269 0 0 0 23 111 21 54 116 106 116 238 484
2022/20232.470 281 155 344 236 377 696 15 101 162 10 49 44
2023/20241.194 52 86 86 113 70 197 128 77 2 39 248 96
2024/20254.523 294 279 179 797 162 50 108 477 519 241 358 1.059
2025/202612.324 1.135 679 684 1.827 2.694 875 1.310 968 896 596 240 420
2026/20273.061 207 385 622 1.847 0 0 0 0 0 0 0 0
Totale 27.788